EQUASENS (EQS.PA) Stock Fundamental Analysis
Europe - EPA:EQS - FR0012882389 - Common Stock
41.65 EUR
-0.35 (-0.83%)
We assign a fundamental rating of 6 out of 10 to EQS. EQS was compared to 12 industry peers in the Health Care Technology industry. EQS has an excellent profitability rating, but there are some minor concerns on its financial health. EQS has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year EQS was profitable.
EQS had a positive operating cash flow in the past year.
In the past 5 years EQS has always been profitable.
Each year in the past 5 years EQS had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.84%, EQS is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
The Return On Equity of EQS (15.79%) is better than 91.67% of its industry peers.
EQS's Return On Invested Capital of 12.70% is amongst the best of the industry. EQS outperforms 91.67% of its industry peers.
EQS had an Average Return On Invested Capital over the past 3 years of 15.18%. This is significantly above the industry average of 9.21%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROIC | 12.7% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
EQS's Profit Margin of 16.15% is amongst the best of the industry. EQS outperforms 83.33% of its industry peers.
EQS's Profit Margin has been stable in the last couple of years.
EQS has a better Operating Margin (19.80%) than 83.33% of its industry peers.
EQS's Operating Margin has declined in the last couple of years.
EQS's Gross Margin of 68.81% is on the low side compared to the rest of the industry. EQS is outperformed by 66.67% of its industry peers.
In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
EQS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for EQS remains at a similar level compared to 1 year ago.
The number of shares outstanding for EQS has been increased compared to 5 years ago.
EQS has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.93 indicates that EQS is not in any danger for bankruptcy at the moment.
EQS's Altman-Z score of 3.93 is fine compared to the rest of the industry. EQS outperforms 66.67% of its industry peers.
The Debt to FCF ratio of EQS is 0.98, which is an excellent value as it means it would take EQS, only 0.98 years of fcf income to pay off all of its debts.
EQS has a better Debt to FCF ratio (0.98) than 66.67% of its industry peers.
EQS has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.09, EQS is in line with its industry, outperforming 58.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Altman-Z | 3.93 |
ROIC/WACC1.62
WACC7.82%
2.3 Liquidity
EQS has a Current Ratio of 1.29. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.29, EQS perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
EQS has a Quick Ratio of 1.20. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
EQS has a Quick ratio (1.20) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.07%.
EQS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.12% yearly.
The Revenue has been growing slightly by 4.45% in the past year.
Measured over the past years, EQS shows a small growth in Revenue. The Revenue has been growing by 6.45% on average per year.
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
3.2 Future
EQS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.63% yearly.
Based on estimates for the next years, EQS will show a small growth in Revenue. The Revenue will grow by 7.74% on average per year.
EPS Next Y13%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.43, the valuation of EQS can be described as rather expensive.
Based on the Price/Earnings ratio, EQS is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
EQS is valuated rather cheaply when we compare the Price/Earnings ratio to 25.91, which is the current average of the S&P500 Index.
EQS is valuated correctly with a Price/Forward Earnings ratio of 13.15.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EQS indicates a rather cheap valuation: EQS is cheaper than 83.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.57, EQS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.43 | ||
| Fwd PE | 13.15 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EQS indicates a somewhat cheap valuation: EQS is cheaper than 75.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.01 | ||
| EV/EBITDA | 8.69 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of EQS may justify a higher PE ratio.
A more expensive valuation may be justified as EQS's earnings are expected to grow with 18.63% in the coming years.
PEG (NY)1.34
PEG (5Y)3.4
EPS Next 2Y17.52%
EPS Next 3Y18.63%
5. Dividend
5.1 Amount
EQS has a Yearly Dividend Yield of 3.11%.
Compared to an average industry Dividend Yield of 3.53, EQS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, EQS pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
5.2 History
The dividend of EQS is nicely growing with an annual growth rate of 8.00%!
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
51.75% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
The dividend of EQS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.75%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPA:EQS (11/13/2025, 7:00:00 PM)
41.65
-0.35 (-0.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners11.62%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap631.83M
Revenue(TTM)224.73M
Net Income(TTM)36.30M
Analysts83.33
Price Target49.98 (20%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.75%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.01%
PT rev (3m)2.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.82%
EPS NY rev (3m)-11.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.43 | ||
| Fwd PE | 13.15 | ||
| P/S | 2.81 | ||
| P/FCF | 17.01 | ||
| P/OCF | 13.09 | ||
| P/B | 2.75 | ||
| P/tB | 7.91 | ||
| EV/EBITDA | 8.69 |
EPS(TTM)2.39
EY5.74%
EPS(NY)3.17
Fwd EY7.6%
FCF(TTM)2.45
FCFY5.88%
OCF(TTM)3.18
OCFY7.64%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)1.34
PEG (5Y)3.4
Graham Number28.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROCE | 15.59% | ||
| ROIC | 12.7% | ||
| ROICexc | 17.92% | ||
| ROICexgc | 69.44% | ||
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% | ||
| FCFM | 16.53% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-25.09%
ROICexgc growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 69.34% | ||
| Cap/Sales | 4.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.71% | ||
| Profit Quality | 102.29% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 3.93 |
F-Score7
WACC7.82%
ROIC/WACC1.62
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y13%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-8.02%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year59.12%
EBIT Next 3Y27.46%
EBIT Next 5YN/A
FCF growth 1Y-36.73%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-31.7%
OCF growth 3Y0.02%
OCF growth 5Y3.18%
EQUASENS / EQS.PA FAQ
What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.
What is the valuation status for EQS stock?
ChartMill assigns a valuation rating of 6 / 10 to EQUASENS (EQS.PA). This can be considered as Fairly Valued.
What is the profitability of EQS stock?
EQUASENS (EQS.PA) has a profitability rating of 7 / 10.
What is the expected EPS growth for EQUASENS (EQS.PA) stock?
The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 13% in the next year.
Can you provide the dividend sustainability for EQS stock?
The dividend rating of EQUASENS (EQS.PA) is 6 / 10 and the dividend payout ratio is 51.75%.